3655 results for «294»

Filter By

3655 results

Technical decision-making for CTO PCI strategy

22 May 2026 – From EuroPCR 2026

This session focuses on technical decision-making for chronic total occlusion PCI strategy. It presents diverse approaches to right coronary CTOs, complex management involving double rendezvous techniques, subintimal strategies, and innovative single-injection methods, demonstrating the evolving frontiers in CTO intervention.

Challenges for TAVI in bicuspid

22 May 2026 – From EuroPCR 2026

This session addresses the unique challenges encountered during transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves. It covers procedural nuances for type 0 bicuspid valves, risks associated with anomalous coronary anatomy, and complex anatomical considerations such as large annulus and tortuous aorta, culminating...

Challenging PCI on bifurcation lesions

22 May 2026 – From EuroPCR 2026

Addressing the complexities of PCI in bifurcation lesions, this session highlights novel techniques such as the TAP and modified mini-crush methods, alongside strategies for managing challenging coronary anatomy. Validation of novel approaches like POT-side DCB-POT for left main bifurcations is also featured.

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

21 May 2026 – From EuroPCR 2026

This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

When a primary PCI goes wrong

19 May 2026 – From EuroPCR 2026

This session investigates complications encountered during primary percutaneous coronary interventions (PCI). It covers management of no-reflow phenomena, innovative guide extension catheter aspiration techniques for thrombus-rich STEMI, challenges when balloon crossing fails, vein graft PCI pitfalls, and complex concurrent ischemic events involving myocardial infarction and limb ischemia....

Aortic stenosis: from diagnostic to treatment

21 May 2026 – From EuroPCR 2026

This session provides an in-depth review of contemporary management of aortic stenosis, covering diagnostic advancements, temporal trends, and treatment outcomes. It includes insights from the LAPLACE-TAVI registry focusing on low-risk patients, discusses the growing feasibility of day-case TAVI procedures, compares transcatheter and surgical valve replacements in...

How should I treat my CTO? Adapting to local conditions

22 May 2026 – From EuroPCR 2026

This session delves into managing chronic total occlusions (CTO) under resource-limited conditions, highlighting the essential CTO toolbox and strategic procedural planning. It emphasizes that an antegrade-first approach, often with dual arterial access, can achieve high success in many CTO cases, illustrated through complex real-world cases from...

Complex PCI - Best cases from PCR Global Interventional Academy - Part 2

21 May 2026 – From EuroPCR 2026

This session showcases best cases from the PCR Global Interventional Academy focusing on complex PCI scenarios. It addresses challenges such as managing ostial left anterior descending artery lesions, strategies for branch protection, implications of coronary involvement during TAVI, and future directions in complex coronary interventions. The...

Vesalio announces FDA Approval of the NeVa VS™ to treat cerebral vasospasm after aneurysmal rupture

15 Sep 2022

Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial

16 Nov 2024

Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.

Edoardo Zancanaro

Author

Edoardo Zancanaro
ENBALV

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
CLEAR SYNERGY

iFR versus angiography-guided CABG: 3-year results of the iCABG randomised trial

31 Oct 2025

Alex Sticchi provides his take on the iCABG trial presented by Rasa Ordiene at TCT 2025, in San Francisco.

Alessandro Sticchi

Author

Alessandro Sticchi
iFR versus angiography-guided CABG: 3-year results of the iCABG randomized trial

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation
Didn’t find what you were looking for?